AKTX vs IVZ · $17.2M cap vs rev $3.57B
Akari Therapeutics PLC (AKTX) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
AKTX does not have a complete income-statement cache yet.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
AKTX currently screens at market cap $17.2M. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the AKTX and IVZ stock pages for the full models.
Not investment advice.